Using label free quantitative proteomic analyses and MRM-based triple quadrupole mass spectral assay based target groups, two independent studies reported an elevation in the level MDH within cerebrospinal fluid collected from AD patients [183, 184]. Here, MDH2 is linked to Alzheimer disease.